The post Bo Bichette Sends Blue Jays’ Vladimir Guerrero Jr Message With Mets Move ‘Not Going Well’ appeared on BitcoinEthereumNews.com. CHICAGO, ILLINOIS – APRILThe post Bo Bichette Sends Blue Jays’ Vladimir Guerrero Jr Message With Mets Move ‘Not Going Well’ appeared on BitcoinEthereumNews.com. CHICAGO, ILLINOIS – APRIL

Bo Bichette Sends Blue Jays’ Vladimir Guerrero Jr Message With Mets Move ‘Not Going Well’

For feedback or concerns regarding this content, please contact us at crypto.news@mexc.com

CHICAGO, ILLINOIS – APRIL 18: Bo Bichette #19 of the New York Mets looks on against the Chicago Cubs at Wrigley Field on April 18, 2026 in Chicago, Illinois. (Photo by Geoff Stellfox/Getty Images)

Getty Images

Bo Bichette spent years alongside Vladimir Guerrero Jr. as one of the faces of the Toronto Blue Jays franchise.

The two stars were at the center of nearly every major conversation surrounding the organization, from playoff disappointments to contract speculation. Now, a few months into his tenure with the New York Mets, Bichette says his experience in Toronto prepared him for the intense scrutiny that comes with playing in one of baseball’s biggest markets.

As Guerrero prepares for another season as the centerpiece of the Blue Jays after signing a 14-year, $500 million extension, Bichette’s latest comments serve as a reminder of the pressure the pair faced together in Toronto.

ForbesBlue Jays’ John Schneider Sends Message On Trade Deadline Fire Sale

Former Toronto Blue Jays Star Bo Bichette Has Struggled With New York Mets

After reaching free agency for the first time in his career, Bichette signed a three-year contract with the Mets worth $42 million annually. Expectations were high for the four-time All-Star, who entered the season with a .294 career batting average, 111 home runs and an .806 OPS from his seven seasons with Toronto.

Instead, his transition to New York has been anything but smooth.

Mets fans booed Bichette during the opening homestand after he opened the season 1-for-14 with eight strikeouts. Through his first 57 games, he was hitting just .222 with five home runs.

ForbesPhillies’ Home Stadium Becomes Key In $10 Million Star’s Lawsuit With Parents

New York Mets’ Bo Bichette Compares Struggles To Life With Toronto Blue Jays

While New York’s sports media environment is often viewed as unique, Bichette believes he has already experienced something similar.

“That’s what New York is. When it’s not going well, it’s not great, and when it is (going well), it’s great. I haven’t experienced that yet,” Bichette said, according to the Toronto Star’s Mike Wilner. “(There) was a lot of attention surrounding myself and (Vladimir Guerrero Jr.), so when things didn’t go well we caught a lot of the heat for it. So I feel like I’ve been through it, and I don’t feel as if it’s anything more crazy.”

The comments are particularly notable given Guerrero’s current role in Toronto.

With Bichette gone, Guerrero has become the undisputed face of the franchise following his record-setting extension. The Blue Jays are expected to contend again after their World Series appearance, meaning expectations and scrutiny are unlikely to fade anytime soon.

And Bichette’s Mets tenure has not produced the results many expected so far. But given his experience, the former Blue Jays star might bounce back soon and, one day, discover the other side of New York’s spotlight — the version that comes when things are going well.

Source: https://www.forbes.com/sites/peterchawaga/2026/05/31/bo-bichette-sends-blue-jays-vladimir-guerrero-jr-message-with-mets-move-not-going-well/

Market Opportunity
Notcoin Logo
Notcoin Price(NOT)
$0.0004633
$0.0004633$0.0004633
+2.04%
USD
Notcoin (NOT) Live Price Chart

SPACEX(PRE) Launchpad

SPACEX(PRE) LaunchpadSPACEX(PRE) Launchpad

Register for a chance to win a free lucky draw

Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact crypto.news@mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

The post Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution appeared on BitcoinEthereumNews.com. In this week’s edition of InnovationRx, we look at possible pain treatments from cannabis, risks of new vaccine restrictions, virtual clinical trials at the Mayo Clinic, GSK’s $30 billion U.S. manufacturing commitment, and more. To get it in your inbox, subscribe here. Despite their addictive nature, opioids continue to be a major treatment for pain due to a lack of effective alternatives. In an effort to boost new drugs, the FDA released new guidelines for non-opioid painkillers last week. But making these drugs hasn’t been easy. Vertex Pharmaceuticals received FDA approval for its non-opioid Journavx in January, then abandoned a next generation drug after a failed clinical trial earlier this summer. Acadia similarly abandoned a promising candidate after a failed trial in 2022. One possible basis for non-opioids might be cannabis. Earlier this year, researchers at Washington University at St. Louis and Stanford published a study showing that a cannabis-derived compound successfully eased pain in mice with minimal side effects. Munich-based pharmaceutical company Vertanical is perhaps the furthest along in this quest. It is developing a cannabinoid-based extract to treat chronic pain it hopes will soon become an approved medicine, first in the European Union and eventually in the United States. The drug, currently called Ver-01, packs enough low levels of cannabinoids (including THC) to relieve pain, but not so much that patients get high. Founder Clemens Fischer, a 50-year-old medical doctor and serial pharmaceutical and supplement entrepreneur, hopes it will become the first cannabis-based painkiller prescribed by physicians and covered by insurance. Fischer founded Vertanical, with his business partner Madlena Hohlefelder, in 2017, and has invested more than $250 million of his own money in it. With a cannabis cultivation site and drug manufacturing plant in Denmark, Vertanical has successfully passed phase III clinical trials in Germany and expects…
Share
BitcoinEthereumNews2025/09/18 05:26
Bitcoin shorts risk $2.5 billion liquidation at $72K: Are bears in danger?

Bitcoin shorts risk $2.5 billion liquidation at $72K: Are bears in danger?

Bitcoin is poised for a reversal if ETF demand returns or a ceasefire occurs, potentially crushing short sellers in a massive price squeeze.
Share
Coin Telegraph2026/04/04 19:58
Robotics Automation Prototyping: Engineering Kinetic Agility into End-Effectors

Robotics Automation Prototyping: Engineering Kinetic Agility into End-Effectors

Inertia is the invisible tax on modern industrial throughput. Every millisecond a robotic arm spends decelerating, or waiting for high-frequency vibrations to settle
Share
Techbullion2026/04/02 18:25

RealStocks Now Live

RealStocks Now LiveRealStocks Now Live

Trade real U.S. stock via regulated brokerage